SEARCH

SEARCH BY CITATION

References

  • Albrandt K, Mull E, Brady EM, Herich J, Moore CX, Beaumont K (1993). Molecular cloning of two receptors from rat brain with high affinity for salmon calcitonin. FEBS Lett 325: 225232.
  • Alonso V, Ardura JA, Wang B, Sneddon WB, Friedman PA (2011). A naturally occurring isoform inhibits parathyroid hormone receptor trafficking and signaling. J Bone Miner Res 26: 143155.
  • Ardati A, Goetschy V, Gottowick J, Henriot S, Valdenaire O, Deuschle U et al. (1999). Human CRF2 alpha and beta splice variants: pharmacological characterization using radioligand binding and a luciferase gene expression assay. Neuropharmacology 38: 441448.
  • Bazarsuren A, Grauschopf U, Wozny M, Reusch D, Hoffmann E, Schaefer W et al. (2002). In vitro folding, functional characterization, and disulfide pattern of the extracellular domain of human GLP-1 receptor. Biophys Chem 96: 305318.
  • Bergwitz C, Gardella TJ, Flannery MR, Potts JT, Kronenberg HM, Goldring SR et al. (1996). Full activation of chimeric receptors by hybrids between parathyroid hormone and calcitonin. Evidence for a common pattern of ligand-receptor interaction. J Biol Chem 271: 2646926472.
  • Chen R, Lewis KA, Perrin MH, Vale WW (1993). Expression cloning of a human corticotropin-releasing-factor receptor. Proc Natl Acad Sci USA 90: 89678971.
  • Chen AM, Perrin MH, Digruccio MR, Vaughan JM, Brar BK, Arias CM et al. (2005). A soluble mouse brain splice variant of type 2alpha corticotropin-releasing factor (CRF) receptor binds ligands and modulates their activity. Proc Natl Acad Sci USA 102: 26202625.
  • Christopoulos A, Christopoulos G, Morfis M, Udawela M, Laburthe M, Couvineau A et al. (2003). Novel receptor partners and function of receptor activity-modifying proteins. J Biol Chem 278: 32933297.
  • Daniel PB, Kieffer TJ, Leech CA, Habener JF (2001). Novel alternatively spliced exon in the extracellular ligand-binding domain of the pituitary adenylate cyclase-activating polypeptide (PACAP) type 1 receptor (PAC1R) selectively increases ligand affinity and alters signal transduction coupling during spermatogenesis. J Biol Chem 276: 1293812944.
  • Dautzenberg FM, Mevenkamp G, Wille S, Hauger RL (1999). N-terminal splice variants of the type I PACAP receptor: isolation, characterization and ligand binding/selectivity determinants. J Neuroendocrinol 11: 941949.
  • Ding W-Q, Cheng Z-J, McElhiney J, Kuntz SM, Miller LJ (2002a). Silencing of secretin receptor function by dimerization with a misspliced variant secretin receptor in ductal pancreatic adenocarcinoma. Cancer Res 62: 52235229.
  • Ding WQ, Kuntz S, Böhmig M, Wiedenmann B, Miller LJ (2002b). Dominant negative action of an abnormal secretin receptor arising from mRNA missplicing in a gastrinoma*. Gastroenterology 122: 500511.
  • Evans RT, Seasholtz AF (2009). Soluble corticotropin-releasing hormone receptor 2alpha splice variant is efficiently translated but not trafficked for secretion. Endocrinology 150: 41914202.
  • Feyen JH, Cardinaux F, Gamse R, Bruns C, Azria M, Trechsel U (1992). N-terminal truncation of salmon calcitonin leads to calcitonin antagonists. Structure activity relationship of N-terminally truncated salmon calcitonin fragments in vitro and in vivo. Biochem Biophys Res Commun 187: 813.
  • Fredriksson R, Lagerström MC, Lundin L-G, Schiöth HB (2003). The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. Mol Pharmacol 63: 12561272.
  • Gao F, Harikumar KG, Dong M, Lam PC-H, Sexton PM, Christopoulos A et al. (2009). Functional importance of a structurally distinct homodimeric complex of the family B G protein-coupled secretin receptor. Mol Pharmacol 76: 264274.
  • Gelling RW, Wheeler MB, Xue J, Gyomorey S, Nian C, Pederson RA et al. (1997). Localization of the domains involved in ligand binding and activation of the glucose-dependent insulinotropic polypeptide receptor. Endocrinology 138: 26402643.
  • Goldman ME, McKee RL, Caulfield MP, Reagan JE, Levy JJ, Gay CT et al. (1988). A new highly potent parathyroid hormone antagonist: [D-Trp12,Tyr34]bPTH-(7-34)NH2. Endocrinology 123: 25972599.
  • Gorn AH, Lin HY, Yamin M, Auron PE, Flannery MR, Tapp DR et al. (1992). Cloning, characterization, and expression of a human calcitonin receptor from an ovarian carcinoma cell line. J Clin Invest 90: 17261735.
  • Grace CRR, Perrin MH, DiGruccio MR, Miller CL, Rivier JE, Vale WW et al. (2004). NMR structure and peptide hormone binding site of the first extracellular domain of a type B1 G protein-coupled receptor. Proc Natl Acad Sci USA 101: 1283612841.
  • Grace CRR, Perrin MH, Gulyas J, Digruccio MR, Cantle JP, Rivier JE et al. (2007). Structure of the N-terminal domain of a type B1 G protein-coupled receptor in complex with a peptide ligand. Proc Natl Acad Sci USA 104: 48584863.
  • Grauschopf U, Lilie H, Honold K, Wozny M, Reusch D, Esswein A et al. (2000). The N-terminal fragment of human parathyroid hormone receptor 1 constitutes a hormone binding domain and reveals a distinct disulfide pattern. Biochemistry 39: 88788887.
  • Haar ET, Koth CM, Abdul-Manan N, Swenson L, Coll JT, Lippke JA et al. (2010). Crystal structure of the ectodomain complex of the CGRP receptor, a class-B GPCR, reveals the site of drug antagonism. Structure 18: 10831093.
  • Harikumar KG, Pinon DI, Miller LJ (2007). Transmembrane segment IV contributes a functionally important interface for oligomerization of the Class II G protein-coupled secretin receptor. J Biol Chem 282: 3036330372.
  • Harikumar KG, Happs RM, Miller LJ (2008). Dimerization in the absence of higher-order oligomerization of the G protein-coupled secretin receptor. Biochim Biophys Acta 1778: 25552563.
  • Harikumar KG, Ball AM, Sexton PM, Miller LJ (2010). Importance of lipid-exposed residues in transmembrane segment four for family B calcitonin receptor homo-dimerization. Regul Pept 164: 113119.
  • Holtmann MH, Hadac EM, Miller LJ (1995). Critical contributions of amino-terminal extracellular domains in agonist binding and activation of secretin and vasoactive intestinal polypeptide receptors. Studies of chimeric receptors. J Biol Chem 270: 1439414398.
  • Houssami S, Findlay DM, Brady CL, Myers DE, Martin TJ, Sexton PM (1994). Isoforms of the rat calcitonin receptor: consequences for ligand binding and signal transduction. Endocrinology 135: 183190.
  • Huang C-C, Tesmer JJG (2011). Recognition in the face of diversity: interactions of heterotrimeric G proteins and G protein-coupled receptor (GPCR) kinases with activated GPCRs. J Biol Chem 286: 77157721.
  • Jaillon O, Aury J-M, Brunet F, Petit J-L, Stange-Thomann N, Mauceli E et al. (2004). Genome duplication in the teleost fish Tetraodon nigroviridis reveals the early vertebrate proto-karyotype. Nature 431: 946957.
  • Journot L, Waeber C, Pantaloni C, Holsboer F, Seeburg PH, Bockaert J et al. (1995). Differential signal transduction by six splice variants of the pituitary adenylate cyclase-activating peptide (PACAP) receptor. Biochem Soc Trans 23: 133137.
  • Koole C, Wootten D, Simms J, Valant C, Sridhar R, Woodman OL et al. (2010). Allosteric ligands of the glucagon-like peptide 1 receptor (GLP-1R) differentially modulate endogenous and exogenous peptide responses in a pathway-selective manner: implications for drug screening. Mol Pharmacol 78: 456465.
  • Kostich WA, Chen A, Sperle K, Largent BL (1998). Molecular identification and analysis of a novel human corticotropin-releasing factor (CRF) receptor: the CRF2gamma receptor. Mol Endocrinol 12: 10771085.
  • Kraetke O, Wiesner B, Eichhorst J, Furkert J, Bienert M, Beyermann M (2005). Dimerization of corticotropin-releasing factor receptor type 1 is not coupled to ligand binding. J Recept Signal Transduct Res 25: 251276.
  • Lisenbee CS, Dong M, Miller LJ (2005). Paired cysteine mutagenesis to establish the pattern of disulfide bonds in the functional intact secretin receptor. J Biol Chem 280:1233012338.
  • Lutz EM, Ronaldson E, Shaw P, Johnson MS, Holland PJ, Mitchell R (2006). Characterization of novel splice variants of the PAC1 receptor in human neuroblastoma cells: consequences for signaling by VIP and PACAP. Mol Cell Neurosci 31: 193209.
  • Markovic D, Papadopoulou N, Teli T, Randeva H, Levine MA, Hillhouse EW et al. (2006). Differential responses of corticotropin-releasing hormone receptor type 1 variants to protein kinase C phosphorylation. J Pharmacol Exp Ther 319: 10321042.
  • Markovic D, Lehnert H, Levine MA, Grammatopoulos DK (2008). Structural determinants critical for localization and signaling within the seventh transmembrane domain of the type 1 corticotropin releasing hormone receptor: lessons from the receptor variant R1d. Mol Endocrinol 22: 25052519.
  • Matsumoto M, Kaibara M, Uezono Y, Izumi F, Sumikawa K, Sexton PM et al. (1998). Function of the rat calcitonin receptors, C1a and C1b, expressed in Xenopus oocytes. Biochem Biophys Res Commun 242: 484491.
  • Montrose-Rafizadeh C, Yang H, Rodgers BD, Beday A, Pritchette LA, Eng J (1997). High potency antagonists of the pancreatic glucagon-like peptide-1 receptor. J Biol Chem 272: 2120121206.
  • Moore EE, Kuestner RE, Stroop SD, Grant FJ, Matthewes SL, Brady CL et al. (1995). Functionally different isoforms of the human calcitonin receptor result from alternative splicing of the gene transcript. Mol Endocrinol 9: 959968.
  • Mustafa T, Grimaldi M, Eiden LE (2007). The hop cassette of the PAC1 receptor confers coupling to Ca2+ elevation required for pituitary adenylate cyclase-activating polypeptide-evoked neurosecretion. J Biol Chem 282: 80798091.
  • Mustafa T, Walsh J, Grimaldi M, Eiden LE (2010). PAC1hop receptor activation facilitates catecholamine secretion selectively through 2-APB-sensitive Ca(2+) channels in PC12 cells. Cell Signal 22: 14201426.
  • Nabhan C, Xiong Y, Xie LY, Abou-Samra AB (1995). The alternatively spliced type II corticotropin-releasing factor receptor, stably expressed in LLCPK-1 cells, is not well coupled to the G protein(s). Biochem Biophys Res Commun 212: 10151021.
  • Nag K, Kato A, Sultana N, Ogoshi M, Takei Y, Hirose S (2007a). Fish calcitonin receptor has novel features. Gen Comp Endocrinol 154: 4858.
  • Nag K, Sultana N, Kato A, Hirose S (2007b). Headless splice variant acting as dominant negative calcitonin receptor. Biochem Biophys Res Commun 362: 10371043.
  • Nussenzveig DR, Mathew S, Gershengorn MC (1995). Alternative splicing of a 48-nucleotide exon generates two isoforms of the human calcitonin receptor. Endocrinology 136: 20472051.
  • Pal K, Swaminathan K, Xu HE, Pioszak AA (2010). Structural basis for hormone recognition by the human CRFR2{alpha} G protein-coupled receptor. J Biol Chem 285: 4035140361.
  • Parthier C, Kleinschmidt M, Neumann P, Rudolph R, Manhart S, Schlenzig D et al. (2007). Crystal structure of the incretin-bound extracellular domain of a G protein-coupled receptor. Proc Natl Acad Sci USA 104: 1394213947.
  • Perrin MH, Fischer WH, Kunitake KS, Craig AG, Koerber SC, Cervini LA et al. (2001). Expression, purification, and characterization of a soluble form of the first extracellular domain of the human type 1 corticotropin releasing factor receptor. J Biol Chem 276: 3152831534.
  • Perrin MH, DiGruccio MR, Koerber SC, Rivier JE, Kunitake KS, Bain DL et al. (2003). A soluble form of the first extracellular domain of mouse type 2beta corticotropin-releasing factor receptor reveals differential ligand specificity. J Biol Chem 278: 1559515600.
  • Pioszak AA, Xu HE (2008). Molecular recognition of parathyroid hormone by its G protein-coupled receptor. Proc Natl Acad Sci USA 105: 50345039.
  • Pioszak AA, Parker NR, Suino-Powell K, Xu HE (2008). Molecular recognition of corticotropin-releasing factor by its G-protein-coupled receptor CRFR1. J Biol Chem 283: 3290032912.
  • Pisarchik A, Slominski AT (2001). Alternative splicing of CRH-R1 receptors in human and mouse skin: identification of new variants and their differential expression. FASEB J 15: 27542756.
  • Pisegna JR, Wank SA (1996). Cloning and characterization of the signal transduction of four splice variants of the human pituitary adenylate cyclase activating polypeptide receptor. Evidence for dual coupling to adenylate cyclase and phospholipase C. J Biol Chem 271: 1726717274.
  • Pisegna JR, Moody TW, Wank SA (1996). Differential signaling and immediate-early gene activation by four splice variants of the human pituitary adenylate cyclase-activating polypeptide receptor (hPACAP-R). Ann NY Acad Sci 805: 5464; discussion 64–56.
  • Raggatt LJ, Evdokiou A, Findlay DM (2000). Sustained activation of Erk1/2 MAPK and cell growth suppression by the insert-negative, but not the insert-positive isoform of the human calcitonin receptor. J Endocrinol 167: 93105.
  • Ross PC, Kostas CM, Ramabhadran TV (1994). A variant of the human corticotropin-releasing factor (CRF) receptor: cloning, expression and pharmacology. Biochem Biophys Res Commun 205: 18361842.
  • Runge S, Wulff BS, Madsen K, Bräuner-Osborne H, Knudsen LB (2003). Different domains of the glucagon and glucagon-like peptide-1 receptors provide the critical determinants of ligand selectivity. Br J Pharmacol 138: 787794.
  • Runge S, Thøgersen H, Madsen K, Lau J, Rudolph R (2008). Crystal structure of the ligand-bound glucagon-like peptide-1 receptor extracellular domain. J Biol Chem 283: 1134011347.
  • Sammeth M, Foissac S, Guigo R (2008). A general definition and nomenclature for alternative splicing events. PLoS Comput Biol 4: e1000147.
  • Sexton PM, Houssami S, Hilton JM, O'Keeffe LM, Center RJ, Gillespie MT et al. (1993). Identification of brain isoforms of the rat calcitonin receptor. Mol Endocrinol 7: 815821.
  • Spengler D, Waeber C, Pantaloni C, Holsboer F, Bockaert J, Seeburg P et al. (1993). Differential signal transduction by five splice variants of the PACAP receptor. 365: 170175.
  • Stroop SD, Kuestner RE, Serwold TF, Chen L, Moore EE (1995). Chimeric human calcitonin and glucagon receptors reveal two dissociable calcitonin interaction sites. Biochemistry 34: 10501057.
  • Sun C, Song D, Davis-Taber RA, Barrett LW, Scott VE, Richardson PL et al. (2007). Solution structure and mutational analysis of pituitary adenylate cyclase-activating polypeptide binding to the extracellular domain of PAC1-RS. Proc Natl Acad Sci USA 104: 78757880.
  • Teli T, Markovic D, Hewitt ME, Levine MA, Hillhouse EW, Grammatopoulos DK (2008). Structural domains determining signalling characteristics of the CRH-receptor type 1 variant R1beta and response to PKC phosphorylation. Cell Signal 20: 4049.
  • Tseng CC, Kieffer TJ, Jarboe LA, Usdin TB, Wolfe MM (1996). Postprandial stimulation of insulin release by glucose-dependent insulinotropic polypeptide (GIP). Effect of a specific glucose-dependent insulinotropic polypeptide receptor antagonist in the rat. J Clin Invest 98: 24402445.
  • Turner JT, Jones SB, Bylund DB (1986). A fragment of vasoactive intestinal peptide, VIP(10-28), is an antagonist of VIP in the colon carcinoma cell line, HT29. Peptides 7: 849854.
  • Ushiyama M, Ikeda R, Sugawara H, Yoshida M, Mori K, Kangawa K et al. (2007). Differential intracellular signaling through PAC1 isoforms as a result of alternative splicing in the first extracellular domain and the third intracellular loop. Mol Pharmacol 72: 103.
  • Wang MW, Young AA, Rink TJ, Cooper GJ (1991). 8-37h-CGRP antagonizes actions of amylin on carbohydrate metabolism in vitro and in vivo. FEBS Lett 291: 195198.
  • Wietfeld D, Heinrich N, Furkert J, Fechner K, Beyermann M, Bienert M et al. (2004). Regulation of the coupling to different G proteins of rat corticotropin-releasing factor receptor type 1 in human embryonic kidney 293 cells. J Biol Chem 279: 3838638394.
  • Xiong Y, Xie LY, Abou-Samra AB (1995). Signaling properties of mouse and human corticotropin-releasing factor (CRF) receptors: decreased coupling efficiency of human type II CRF receptor. Endocrinology 136: 18281834.
  • Zmijewski MA, Slominski AT (2009a). CRF1 receptor splicing in epidermal keratinocytes: potential biological role and environmental regulations. J Cell Physiol 218: 593602.
  • Zmijewski MA, Slominski AT (2009b). Modulation of corticotropin releasing factor (CRF) signaling through receptor splicing in mouse pituitary cell line AtT-20–emerging role of soluble isoforms. J Physiol Pharmacol 60 (Suppl. 4): 3946.
  • Zmijewski MA, Slominski AT (2010). Emerging role of alternative splicing of CRF1 receptor in CRF signaling. Acta Biochim Pol 57: 113.